RECRUITING

Cancer Genetic Testing in Ethnic Populations

Talk to us

Conditions

Breast CarcinomaCarcinoma of Unknown PrimaryCentral Nervous System CarcinomaDigestive System CarcinomaGenitourinary System CarcinomaHead and Neck CarcinomaMalignant Brain NeoplasmMalignant Female Reproductive System NeoplasmMalignant Musculoskeletal NeoplasmMalignant Solid NeoplasmSkin Carcinoma

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratification and individualized screening in these ethnic populations.

Official Title

GEMINI - Cancer Genetic Testing in Ethnic Populations

Quick Facts

Study Start:2019-12-13
Study Completion:2024-10-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04475640

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients at least 18 years of age
  2. * Individuals diagnosed with any solid tumor cancer including, but not limited to, gastrointestinal, breast, gynecological, genitourinary, skin, central nervous system (CNS)/brain, head/neck, musculoskeletal or cancer of unknown primary; and presenting to Mayo Clinic (MC Arizona or MC Florida) for clinical management/treatment; and patients receive genetic testing as described above
  3. * Self-identified as being from various ethnic populations including Hispanic/Latino, Native American/Alaskan, African American (including of African descent), Asian and other European populations
  4. * Blood collection is feasible (health, access and/or tolerability) for requested blood sample(s)
  5. * Individuals have agreed to participate and signed the study informed consent form
  1. * Patients who have had prior germline genetic testing involving a 40+ gene panel within the last 24 months at Mayo Clinic and available for review by the research coordinator at time of consent
  2. * Past or current history of hematological cancer (including leukemias, multiple myeloma)
  3. * All bone marrow transplants

Contacts and Locations

Study Contact

Clinical Trials Referral Office
CONTACT
855-776-0015
mayocliniccancerstudies@mayo.edu

Principal Investigator

Jewel Samadder, M.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Arizona
Scottsdale, Arizona, 85259
United States
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Jewel Samadder, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-12-13
Study Completion Date2024-10-15

Study Record Updates

Study Start Date2019-12-13
Study Completion Date2024-10-15

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Carcinoma
  • Carcinoma of Unknown Primary
  • Central Nervous System Carcinoma
  • Digestive System Carcinoma
  • Genitourinary System Carcinoma
  • Head and Neck Carcinoma
  • Malignant Brain Neoplasm
  • Malignant Female Reproductive System Neoplasm
  • Malignant Musculoskeletal Neoplasm
  • Malignant Solid Neoplasm
  • Skin Carcinoma